[EN] PTERIDINONES AS INHIBITORS OF POLO - LIKE KINASE<br/>[FR] PTÉRIDINONES EN TANT QU'INHIBITEURS DE POLO-LIKE KINASE
申请人:ELAN PHARM INC
公开号:WO2011079114A1
公开(公告)日:2011-06-30
The present invention provides compounds having a structure according to Formula (I) or a salt or solvate thereof, wherein ring A, X, R1, R2, R3, R4, R5 and R6, are defined herein. The invention further provides pharmaceutical compositions including the compounds of the invention and methods of making and using the compounds and compositions of the invention, e.g., in the treatment and prevention of various disorders, such as Parkinson's disease.
Conversion of tryptophan into ß-carboline derivatives
申请人:LEK Pharmaceuticals d.d.
公开号:EP2107059A1
公开(公告)日:2009-10-07
The invention belongs in the field of organic chemistry and relates to a new shortened Pictet-Spengler type reaction for preparing isomerically pure β-carboline compounds useful for the synthesis of tadalafil.
[EN] CONVERSION OF TRYPTOPHAN INTO ß-CARBOLINE DERIVATIVES<br/>[FR] CONVERSION DU TRYPTOPHANE EN DÉRIVÉS DE ?-CARBOLINE
申请人:LEK PHARMACEUTICALS
公开号:WO2009121791A1
公开(公告)日:2009-10-08
The invention belongs in the field of organic chemistry and relates to a new shortened Pictet- Spengler type reaction for preparing isomerically pure ß-carboline compounds useful for the synthesis of tadalafil.
CREATINE ESTER PRONUTRIENT COMPOUNDS AND FORMULATIONS
申请人:Vennerstrom L. Jonathan
公开号:US20070203076A1
公开(公告)日:2007-08-30
The present invention describes a method for providing creatine to an animal, which includes receiving a creatine ester by the animal. The creatine ester is suitable for being modified by the animal to form creatine.
[EN] PTERIDINONES AS INHIBITORS OF POLO-LIKE KINASE<br/>[FR] PTÉRIDINONES EN TANT QU'INHIBITEURS DE POLO-LIKE KINASE
申请人:ELAN PHARM INC
公开号:WO2011079118A1
公开(公告)日:2011-06-30
The present invention provides compounds having a structure according to Formula (I): or a salt or solvate thereof, wherein ring A, E1, E2, R1, R2, R3 and R4 are defined herein. The invention further provides pharmaceutical compositions including the compounds of the invention and methods of making and using the compounds and compositions of the invention, e.g., in the treatment and prevention of various disorders, such as Parkinson's disease.